Dergiler / Eastern Journal of Medicine / 2021 / Cilt: 26 - Sayı: 2

The role of Human Cytomegalovirus (HCMV) in Patients with Active Coeliac Disease (CD)

Sayfa
204–209
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Further studies are needed in detail to understand HCMV immune-pathological effect and to develop new strategies for targeted therapeutic interventions.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Researchers have recently increased their focus on the link between autoimmune diseases and infections.
📊
Temel Bulgular & Veri:Serum samples were obtained from 60 patients with CD, and from 60 healthy subjects.
💡
Sonuç & Katkı:Further studies are needed in detail to understand HCMV immune-pathological effect and to develop new strategies for targeted therapeutic interventions.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Researchers have recently increased their focus on the link between autoimmune diseases and infections. Most of the recent research indicates that silent human cytomegalovirus (HCMV), may have diverse roles in the initiation, development, and exacerbation of autoimmune diseases, such as coeliac Disease (CD) and inflammatory bowel disease. The aim of this study is to evaluate the role of HCMV infection in Iraqi patients with CD. Serum samples were obtained from 60 patients with CD, and from 60 healthy subjects. Enzyme-linked immunosorbent assay was used to determine the Anti-Transglutaminase IgG/IgA, Anti-gliadin IgA/ IgG, as well as the HCMV IgM/ IgG levels in the serum samples. Significantly higher percentage of positivity for serum Anti-transglutaminase (100% vs 0%. p=0.00), serum Anti-gliadin A (96.7% vs. 13.3%, p=0.00) and serum Anti-gliadin G (90% vs. 13.3%, p=0.00) in active CD patients from the healthy controls. Serum Anti-HCMV IgM were detected equally in (3.3%) among both in CD patients and controls whereas serum Anti-HCMV IgG in both CD patients and the controls were (76.7% vs.78.3% , p=0.827). The mean concentrations of studied specific antibodies for CD in patient’s serum are highly significant associated with positive anti-HCMV IgG compared to controls. HCMV infections could participate in the immunopathogenesis of CD whether it’s an autoimmune triggering factor, or may be coexist during immunosuppressive state of the disease, all of which can further worsen the disease prognosis. Further studies are needed in detail to understand HCMV immune-pathological effect and to develop new strategies for targeted therapeutic interventions.

🔖

Bu Makaleye Atıf Yap

SHARQUIE, I. K., ABDULLAH, S. F., BAYATI, A. M. A. (2021). The role of Human Cytomegalovirus (HCMV) in Patients with Active Coeliac Disease (CD). Eastern Journal of Medicine, Cilt: 26 - Sayı: 2, 204–209. https://ajindex.com/articles/210640

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Lerner A, Arleevskaya M, Schmiedl A, Matthias T. Microbes and Viruses Are Bugging the Gut in Celiac Disease. Are They Friends or Foes? Front Microbiol 2017; 8: 1392
  2. Anis S, Kumar R, Abbas Z, Hassan SM, Luck NH, Muzaffar R. Coeliac disease and multiple immunodeficiencies: case report of a diagnostic dilemma. J Pak Med Assoc 2012; 62: 730-732
  3. Chen A, Linz CM, Tsay JL, Jin M, El-Dika SS. Celiac Crisis Associated with Herpes Simplex Virus Esophagitis. ACG Case Rep J 2016; 3(4): e159-e
  4. Rafailidis PI, Mourtzoukou EG, Varbobitis IC, Falagas ME. Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J 2008; 5: 47
  5. Nikolich-Žugich J, van Lier RAW. Cytomegalovirus (CMV) research in immune senescence comes of age: overview of the 6th International Workshop on CMV and Immunosenescence. Geroscience 2017; 39: 245-249
  6. Chiereghin A, Potena L, Borgese L, Gibertoni D, Squarzoni D, Turello G, et al. Monitoring of Cytomegalovirus (CMV)-Specific Cell-Mediated Immunity in Heart Transplant Recipients: Clinical Utility of the QuantiFERON-CMV Assay for Management of Posttransplant CMV Infection. J Clin Microbiol 2018; 56: e01040-17
  7. Haese N, Burg J, Ando T, Jones I, Kreklywich C, Orloff S, et al. Depletion of macrophages from Cytomegalovirus (CMV) latently infected donor allografts decreases CMV mediated immunopathology and prevents CMV-accelerated chronic rejection. The Journal of Immunology 2018; 200: 55.25-55.25
  8. Kelly E, Cullen G, Aftab AR, Courtney G. Coeliac crisis presenting with cytomegalovirus hepatitis. European journal of gastroenterology & hepatology 2006; 18: 793-795
  9. Nemes E. Pathologic antibody responses in celiac disease: specificity and immunological correlations. PhD Thesis. University of Debrecen: Debrecen. 2008. Avaliable from:
  10. Plot L, Amital H, Barzilai O, Ram M, Nicola B, Shoenfeld Y. Infections May Have a Protective Role in the Etiopathogenesis of Celiac Disease. Annals of the New York Academy of Sciences 2009; 1173: 670-674
  11. Jansen MA, van den Heuvel D, van der Zwet KV, Jaddoe VW, Hofman A, Escher JC, et al. Herpesvirus Infections and Transglutaminase Type 2 Antibody Positivity in Childhood: The Generation R Study. Journal of pediatric gastroenterology and nutrition 2016; 63: 423-430
  12. CDC. Cytomegalovirus (CMV) and congenital CMV infection, Centers for Disease Contr